GPCR

IPO initial public offering

Biotech

Septerna goes public with upsized offering of $288M

Septerna has scored with an upsized IPO of $288M, which exceeded the $157.9M the company said it expected to generate early this week.

Kevin Dunleavy Oct 25, 2024 10:29am

IPO

GPCR firm Septerna files for IPO on strength of preclinical data

Oct 3, 2024 6:00am

Light speed travel time warp traveling in outer space galaxy

Lilly-backed Superluminal speeds toward the clinic with $120M

Sep 9, 2024 7:00am

Avrobio's corporate tremor attracts Tectonic for reverse merger

Jan 30, 2024 3:24pm

Deal terminate tear up end deal scrap

GSK jilts Sosei, axing bowel disease drug amid immunology pivot

Nov 27, 2023 5:00am

pile of cash piggy bank money cash dollars bills spend

Vertex gets in on GPCR game, paying Septerna $47M for program

Sep 12, 2023 9:05am